LifeNet Health begins production of ViviGen cellular bone matrix at new US facility

348

LifeNet Health has begun production of ViviGen cellular bone matrix in its Northwest headquarters in Renton, USA. ViviGen, a cellular allograft developed by LifeNet Health, incorporates viable bone cells that support the healing process.

“Part of our mission at LifeNet Health is to continually advance how the gift of donated tissues can improve patients’ lives,” says Levi Anderson, general manager, LifeNet Health Northwest Operations. “We are excited to bring the processing technology behind ViviGen to our Pacific Northwest location.”

Launched in 2014, ViviGen is the result of a four-year research and development process, during which LifeNet Health explored new techniques for tissue recovery, preparation, preservation and packaging to maintain bone cell viability.

LifeNet Health has also completed the design and buildout of a nearly 2,000-square-foot suite dedicated to ViviGen production.